Skip to main content
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1990 Jan;152(1):78–81.

Vitamin A--a pregnancy hazard alert.

K W Kizer 1, A M Fan 1, J Bankowska 1, R J Jackson 1, D O Lyman 1
PMCID: PMC1002277  PMID: 2309485

Abstract

Vitamin A is essential to human health, but concerns have arisen recently regarding its potential teratogenicity. Human and animal birth defects have been associated with the use of the vitamin A analogue, isotretinoin, or Accutane, for acne treatment, although the association of such defects with vitamin A itself is unclear. The federal Food and Drug Administration is evaluating the health issues surrounding vitamin A and, together with the manufacturer, has developed restrictions and label warnings to ensure the appropriate use of Accutane. We also have evaluated these issues, with concerns about the possible teratogenicity of high vitamin A intake during pregnancy. Practitioners should be familiar with the possible hazard of excessive dosages of vitamin A and its analogues. Vitamin A daily doses of higher than 8,000 IU for pregnant woman are not necessary for good health and are not recommended. Foods high in beta-carotene can provide the necessary amounts of vitamin A and, in contrast to the synthetic analogues, their use has not been associated with vitamin A toxicity or teratogenicity in humans or animals.

Full text

PDF
78

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lammer E. J., Chen D. T., Hoar R. M., Agnish N. D., Benke P. J., Braun J. T., Curry C. J., Fernhoff P. M., Grix A. W., Jr, Lott I. T. Retinoic acid embryopathy. N Engl J Med. 1985 Oct 3;313(14):837–841. doi: 10.1056/NEJM198510033131401. [DOI] [PubMed] [Google Scholar]
  2. Lammer E. J. Embryopathy in infant conceived one year after termination of maternal etretinate. Lancet. 1988 Nov 5;2(8619):1080–1081. doi: 10.1016/s0140-6736(88)90101-8. [DOI] [PubMed] [Google Scholar]
  3. Martínez-Frías M. L., Salvador J. Megadose vitamin A and teratogenicity. Lancet. 1988 Jan 30;1(8579):236–236. doi: 10.1016/s0140-6736(88)91082-3. [DOI] [PubMed] [Google Scholar]
  4. Rosa F. W. Teratogenicity of isotretinoin. Lancet. 1983 Aug 27;2(8348):513–513. doi: 10.1016/s0140-6736(83)90538-x. [DOI] [PubMed] [Google Scholar]
  5. Rosa F. W., Wilk A. L., Kelsey F. O. Teratogen update: vitamin A congeners. Teratology. 1986 Jun;33(3):355–364. doi: 10.1002/tera.1420330315. [DOI] [PubMed] [Google Scholar]
  6. Willhite C. C., Hill R. M., Irving D. W. Isotretinoin-induced craniofacial malformations in humans and hamsters. J Craniofac Genet Dev Biol Suppl. 1986;2:193–209. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES